295 related articles for article (PubMed ID: 12133441)
1. [A long-term follow-up study of 50 patients with severe aplastic anemia who have survived more than 3 years after immunosuppressive therapy].
He G; Shao Z; Liu H; Zhang Y; Chen G; Li K; Song L; He H; Zhao M; Fu R; Shi J; Bai J; Zhang H; Chu Y; Yang T; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2002 May; 23(5):229-32. PubMed ID: 12133441
[TBL] [Abstract][Full Text] [Related]
2. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
[TBL] [Abstract][Full Text] [Related]
3. [Colony formation of bone marrow hematopoietic progenitor cells in patients with severe aplastic anemia and its relation to the results of immunosuppressive therapy].
Xia C; Chu Y; Shao Z; Zhang J; Tang X; Tian Z; Chen G; Zhang Y; Zhang J
Zhonghua Xue Ye Xue Za Zhi; 1997 Oct; 18(10):538-40. PubMed ID: 15625831
[TBL] [Abstract][Full Text] [Related]
4. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
5. [The impact of immunosuppressive therapy on genetic instabilities of bone marrow hematopoietic cells in patients with aplastic anemia].
Zhang LH; Wang HJ; Zhang L; Zhou K; Yang DL; Yan ZS; Li HQ; Liu QG; Qi JY; Liu Q; Chu YL; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):728-32. PubMed ID: 19176006
[TBL] [Abstract][Full Text] [Related]
6. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
[TBL] [Abstract][Full Text] [Related]
7. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens.
Zheng Y; Liu Y; Chu Y
Exp Hematol; 2006 Jul; 34(7):826-31. PubMed ID: 16797409
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus as an alternative to cyclosporine in the maintenance phase of immunosuppressive therapy for severe aplastic anemia in children.
Alsultan A; Goldenberg NA; Kaiser N; Graham DK; Hays T
Pediatr Blood Cancer; 2009 May; 52(5):626-30. PubMed ID: 19148946
[TBL] [Abstract][Full Text] [Related]
10. Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the European group for blood and marrow transplantation.
Cesaro S; Marsh J; Tridello G; Rovò A; Maury S; Montante B; Masszi T; Van Lint MT; Afanasyev B; Iriondo Atienza A; Bierings M; Carbone C; Doubek M; Lanino E; Sarhan M; Risitano A; Steinerova K; Wahlin A; Pegoraro A; Passweg J
Acta Haematol; 2010; 124(1):19-22. PubMed ID: 20606411
[TBL] [Abstract][Full Text] [Related]
11. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia.
Chang MH; Kim KH; Kim HS; Jun HJ; Kim DH; Jang JH; Kim K; Jung CW
Eur J Haematol; 2010 Feb; 84(2):154-9. PubMed ID: 19912311
[TBL] [Abstract][Full Text] [Related]
12. Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia?
Song MK; Chung JS; Joo YD; Kim YS; Kim SH; Seol YM; Shin HJ; Choi YJ; Cho GJ
Eur J Haematol; 2009 Jul; 83(1):72-8. PubMed ID: 19220415
[TBL] [Abstract][Full Text] [Related]
13. [Immunosuppressive therapy for adult aplastic anemia in a single institution study].
Iki S; Usuki K; Iijima K; Urabe A
Rinsho Ketsueki; 2005 Apr; 46(4):261-8. PubMed ID: 16444958
[TBL] [Abstract][Full Text] [Related]
14. [Twenty years of severe aplastic anemia treatment at Department of Hematology, University Department of Medicine, Zagreb University Hospital Center, Zagreb, Croatia].
Mrsić M; Seiwerth RS; Labar B; Bogdanić V; Nemet D; Duraković N; Mikulić M; Sertić D; Aurer I; Radman I; Zupancić-Salek S
Acta Med Croatica; 2009 Jun; 63(3):209-14. PubMed ID: 19827347
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of acquired severe aplastic anemia in pediatric patients with immunosuppression and allogeneic stem cell hematopoietic transplant].
Barriga C F; Wietstruck P A; Becker K A; Zúñiga C P; Besa De C P; Alvarez Z M; Ocqueteau T M; Bertín C P
Rev Med Chil; 2007 Nov; 135(11):1421-8. PubMed ID: 18259653
[TBL] [Abstract][Full Text] [Related]
16. Outcome of children with aplastic anemia treated with immunosuppressive therapy.
Pongtanakul B; Das PK; Charpentier K; Dror Y
Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069
[TBL] [Abstract][Full Text] [Related]
17. [Splenectomy in programmed therapy of aplastic anemia].
Mikhaĭlova EA; Savchenko VG; Ustinova EN; Vinogradova MA; Kokhno AV; Karagiulian SR; Danishian KI; Grzhimolovskiĭ AV; Zakharov GN
Ter Arkh; 2006; 78(8):52-7. PubMed ID: 17078218
[TBL] [Abstract][Full Text] [Related]
18. Improved survival in severe acquired aplastic anemia of childhood.
Fouladi M; Herman R; Rolland-Grinton M; Jones-Wallace D; Blanchette V; Calderwood S; Doyle J; Halperin D; Leaker M; Saunders EF; Zipursky A; Freedman MH
Bone Marrow Transplant; 2000 Dec; 26(11):1149-56. PubMed ID: 11149724
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
Kahl C; Leisenring W; Deeg HJ; Chauncey TR; Flowers ME; Martin PJ; Sanders JE; Storb R
Br J Haematol; 2005 Sep; 130(5):747-51. PubMed ID: 16115132
[TBL] [Abstract][Full Text] [Related]
20. T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia.
Bacigalupo A; Valle M; Podestà M; Pitto A; Zocchi E; De Flora A; Pozzi S; Luchetti S; Frassoni F; Van Lint MT; Piaggio G
Exp Hematol; 2005 Jul; 33(7):819-27. PubMed ID: 15963858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
